MicroRNAs as Biomarkers for Personalized Antiplatelet Therapy

Thromb Haemost. 2021 Sep;121(9):1121. doi: 10.1055/a-1559-0690. Epub 2021 Jul 26.

Authors

Mitchell J Moon^{1

2}, Karlheinz Peter^{1

2

3

4}

Affiliations

¹ Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
² Department of Cardiometabolic Health, University of Melbourne, Melbourne, Victoria, Australia.
³ Department of Medicine, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
⁴ Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia.

PMID: 34311491
DOI: 10.1055/a-1559-0690

No abstract available

MeSH terms

Biomarkers / metabolism*
Blood Platelets / metabolism*
Cytoskeleton / metabolism
Humans
In Vitro Techniques
Megakaryocytes / cytology
MicroRNAs / genetics
MicroRNAs / metabolism*
Platelet Aggregation Inhibitors / pharmacology*
Thrombosis / metabolism

Substances

Biomarkers
MIRN204 microRNA, human
MicroRNAs
Platelet Aggregation Inhibitors